RxDoctor Payments Data

Martin Friedlander, MD

Ophthalmology · la Jolla, CANPI 1952318404

Payments from drug & device makers

$10,628in general payments, 2019–2025

Across 19 payments — averaging $559.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon Research LLC$10K
  • Alcon$172
  • Neurotech Pharmaceuticals, Inc.$147
  • Bausch & Lomb Americas Inc.$97
  • Sanofi$91
  • Oyster Point Pharma, Inc.$45
  • plus $76 from 4 others

What the payments were for

  • Speaking & faculty fees$10,00094%
  • Food & beverage$6116%
  • Gifts$170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,628 in reported general payments places this provider in the 80th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California

Medicare billing

Part B allowed, 2024
$14,115
Medicare patients
95
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in la Jolla

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →